We are live on ! Find out more
RM

RP Management Portfolio holdings

AUM $139M
1-Year Est. Return 37.98%
This Fund
S&P 500
This Quarter Est. Return
-35.19%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$322M
AUM Growth
-$120M
Cap. Flow
+$53.7M
Cap. Flow %
16.67%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
EPZM
Epizyme, Inc
EPZM
+$53.7M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 87.96%
2 Miscellaneous 12.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPZM
1
DELISTED
Epizyme, Inc
EPZM
$142M 44.14%
9,166,667
+2,500,000
+37% +$53.7M
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$71.8M 22.3%
2,111,111
– –
IMMU
3
DELISTED
Immunomedics Inc
IMMU
$59M 18.3%
4,373,178
– –
EPZM
4
CALL
DELISTED
Epizyme, Inc
EPZM
$38.8M 12.04%
2,500,000
– –
CYTK icon
5
Cytokinetics
CYTK
$10.8B
$10.3M 3.21%
875,656
– –
VIRX
6
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$53K 0.02%
3,700
– –

Similar funds

PC
Paradoxiom Capital Stamford, Connecticut $154M AUM
LA
LPF Advisors Sarasota, Florida $122M AUM 3.12% 1-Year Est. Return
TP
Thunderbird Partners London, United Kingdom $113M AUM 8.51% 1-Year Est. Return
SC
Serenity Capital Palo Alto, California $167M AUM
MADFP
Michael A Dubis Financial Planning Middleton, Wisconsin $103M AUM
RM
RCF Management Denver, Colorado $103M AUM
NC
Napatree Capital Westerly, Rhode Island $178M AUM 8.09% 1-Year Est. Return
GWA
GGM Wealth Advisors Baltimore, Maryland $180M AUM 10.57% 1-Year Est. Return

RP Management's Q1 2020 Portfolio in Review

As of Q1 2020, RP Management held 6 positions worth $322M, down 27% from $442M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

RP Management deployed $53.7M of net new capital in Q1 2020, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 86% a quarter earlier, followed by Miscellaneous.

  • RP Management added most to Epizyme, Inc in Q1 2020, an estimated $53.7M increase.
  • RP Management's ten largest holdings make up 100% of its $322M portfolio in Q1 2020.
  • RP Management opened 0 new positions and closed 0 in Q1 2020.
  • RP Management's portfolio value fell 27% quarter-over-quarter to $322M.

Based on RP Management's 13F filing for Q1 2020, filed 15 May 2020.